Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 3 Pancreatic Neoplasms 3 Malnutrition 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Lung Neoplasms 2 Locally Advanced Head and Neck Carcinoma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Wilms Tumor 1 Surgery--Complications 1 Sarcoma 1 Prostatic Intraepithelial Neoplasia 1 Peripheral Nervous System Diseases 1 Peptic Ulcer 1 Nutrition Related Cancer 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nasopharyngeal Carcinoma 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Motor Activity 1 Malabsorption Syndromes 1

Interventions

Megestrol Acetate 7 Exercise 6 Standard of Care 4 Blood Specimen Collection 4 Olanzapine 3 Ibuprofen 3 dermcidin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Melatonin 2 Enteral Nutrition 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 bermekimab 1 anamorelin 1 Vitamin D 1 Ultrasonography 1 Retrospective Studies 1 Radiotherapy 1 Powders 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cachexia × Dietary Supplements × Clear all

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡